Serum ferritin in renal cell carcinoma: Effect of tumor size, volume grade, and stage

Indian Journal of Cancer

Volumn 42, Issue 4, 2005, Pages 197-200

  Jeet, Singh Kamal ^a   Singh, S K ^b   Suri, A ^a   Vijjan, V ^a   Goswami, A K ^b   Khullar, M ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Renal cell carcinoma; Serum ferritin; Tumor marker

Indexed keywords

FERRITIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NEPHRECTOMY; NONPARAMETRIC TEST; PATHOLOGY; PREDICTION AND FORECASTING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; FERRITINS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 33644863892     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. De Kernion JB, Belldegrun A. Renal tumors. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr., editors. Campbell's Urology. 6th edition. Philadelphia: Saunders, 1992. pp. 1053-93.
2. Srigley JR, Hutter RVP, Gelb AB, Henson DE. Current prognostic factors- renal cell carcinoma. Cancer 1997;994-6.
3. Nseyo UO, Williams PD, Murphy GP. Clinical significance of erythropoietin levels in renal carcinoma. Urology 1986;28:301-6.
4. Surfin G, Mink I, Fitzpatrick J, Moore R, Murphy GP. Coagulation factors in renal adenocarcinoma. J Urol 1978;119:727-30.
5. Echenique JE and Graham SD. Significance of lipid associated sialic acid and CA 19-9 as tumor markers for renal cell carcinoma. Urology 1988;32:397-400.
6. Babian RJ, Swanson DA. Serum haptoglobin: a nonspecific tumor marker for renal cell carcinoma. South Med J 1982;75:1345-8.
7. Chu TM, Shukla SK, Mittleman AO, Murphy GP. Plasma carcinoembryonic antigen in renal cell carcinoma patients. J Urol 1974;111:742-4.
8. Mufti GJ, Hamplin TJ, Stevens J. Basic isoferritin and hypercalcemia in RCC. J Clin Pathology 1982;31:316-8.
9. Fleming S. Immunocytochemical localization of ferritin in kidney and renal tumors. Eur Urol 1987;13:407-11.
10. Kirkali Z, Esen A, Kirkali G, Guner G. Ferritin: A tumor marker expressed by RCC. Eur Urol 1995;28:131-4.
11. Ozen H, Uygur C, Sahin A, Tekgul S, Egen A and Remzi D. Clinical significance of serum ferritin in patients with RCC. Urology 1995;46:494-8.
12. Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J, et al. Serum ferritin as a clinical marker of renal cell carcinoma: influence of tumor volume. Urology 1995;45: 211-7.
13. Jacobs A, Path FR, Worwood M. Ferritin in serum, clinical and biochemical implications. N Eng J Med 1975;292:951-6.
14. Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY. Serum ferritin concentration in early breast cancer. Br J Cancer 1976;34:286-90.
15. Kew MC, Torrance JD, Derman D, Simon M, Macnab GM, Charlton RW, et al. Serum and tumor ferritins in primary liver cancer. Gut 1978;19:294-9.
16. Matzner Y, Konjin AM, Hershko C. Serum ferritin in hematological malignancies. Am J Hematol 1980;9:13-22.
17. Mason DY, Taylor CR. Distribution of transferring, ferritin and lactoferritin in human tissues. J Clin Pathology 1978;31:316-27.
18. Esen AA, Ozen H, Ayhan A, Ergen A, Tasar C, Remzi F. Serum Ferritin: A Tumor marker for renal cell carcinoma. J Urol 1991;145:1134-7.
19. Ziya Kirkali, Guzelosy M, Mugen MU, Kirkali G, Yorukoglu K. Serum ferritin as a clinical marker for RCC. Influence of tumor size and volume. Urologia Internat 1999;62:21-5.